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Abstract 
Background: General practitioners (GPs) play a key role in managing the COVID‑19 outbreak. However, they may 
encounter difficulties adapting their practices to the pandemic. We provide here an analysis of guidelines for the 
reorganisation of GP surgeries during the beginning of the pandemic from 15 countries.
Methods: A network of GPs collaborated together in a three‑step process: (i) identification of key recommendations 
of GP surgery reorganisation, according to WHO, CDC and health professional resources from health care facilities; (ii) 
collection of key recommendations included in the guidelines published in 15 countries; (iii) analysis, comparison and 
synthesis of the results.
Results: Recommendations for the reorganisation of GP surgeries of four types were identified: (i) reorganisation of 
GP consultations (cancelation of non‑urgent consultations, follow‑up via e‑consultations), (ii) reorganisation of GP sur‑
geries (area partitioning, visual alerts and signs, strict hygiene measures), (iii) reorganisation of medical examinations 
by GPs (equipment, hygiene, partial clinical examinations, patient education), (iv) reorganisation of GP staff (equip‑
ment, management, meetings, collaboration with the local community).
Conclusions: We provide here an analysis of guidelines for the reorganisation of GP surgeries during the begin‑
ning of the COVID‑19 outbreak from 15 countries. These guidelines focus principally on clinical care, with less atten‑
tion paid to staff management, and the area of epidemiological surveillance and research is largely neglected. The 
differences of guidelines between countries and the difficulty to apply them in routine care, highlight the need of 
advanced research in primary care. Thereby, primary care would be able to provide recommendations adapted to the 
real‑world settings and with stronger evidence, which is especially necessary during pandemics.
Keywords: COVID‑19, General Practitioner, Primary care, Clinical Practice Guidelines, Pandemic
© The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which 
permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the 
original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or 
other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line 
to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory 
regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this 
licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/. The Creative Commons Public Domain Dedication waiver (http:// creat iveco 
mmons. org/ publi cdoma in/ zero/1. 0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Open Access
*Correspondence:  rosy.tsopra@nhs.net
1 INSERM, Université de Paris, Sorbonne Université, Centre de Recherche 
des Cordeliers, Information Sciences to support Personalized Medicine, 
F‑75006 Paris, France
Full list of author information is available at the end of the article
Page 2 of 16Tsopra et al. BMC Fam Pract           (2021) 22:96 
Background
In December 2019, China declared its first cases of 
COVID-19 in Wuhan, Hubei Province [1]. The causal 
agent, SARS-CoV-2, then rapidly spread around the 
world, leading to the declaration of a pandemic by the 
World Health Organisation (WHO) on March  11th, 2020 
[2]. All countries worldwide are now battling SARS-
CoV-2 and dealing with the healthcare burden it repre-
sents [3]. The main challenge is “resisting” the spread of 
the virus and ensuring that emergency and intensive care 
units are not overwhelmed by massive surges in patient 
numbers.
General practitioners (GPs) are on the frontline in the 
battle against COVID-19 and have a key role to play in 
the management of the crisis. They are involved in the 
education, triage and diagnosis of patients [4, 5], and in 
screening for those at risk of developing severe symp-
toms. GPs can greatly alleviate the burden on hospital 
by dealing with non-severe forms of COVID-19, which 
account for most cases [6]. Given the risk of GP expo-
sure to the virus [6–8] and of transmitting SARS-CoV-2 
to vulnerable patients, it was crucial for GPs to adapt 
their surgeries and practices rapidly to the pandemic. 
This has led to the adoption of telemedicine [7, 9, 10]; the 
equipment of GPs with personal protective equipment 
(PPE); and the provision of masks to COVID-19 patients 
in some cases, to prevent the spread of the disease [7, 
11]. However, some GPs, particularly those working in 
smaller practices, have encountered difficulties introduc-
ing such changes [12].
Several countries have developed national guide-
lines for primary care organisation to assist GPs. These 
guidelines highlight the need to reorganise GP surger-
ies for the safe management of patients with COVID-19, 
but also to provide continuity of care for all, regardless 
COVID-19 status [13]. However, the contents of the 
guidelines differ between countries, and some coun-
tries have yet to issue recommendations for primary 
care. We felt that it would be useful to have an over-
view of these guidelines, to facilitate decision-making in 
countries that have yet to establish guidelines, and for 
future reference, for country-by-country assessments 
of the impact of national initiatives on the course of the 
epidemic.
We therefore aim here to provide a multi-country 
analysis of the reorganisation of GP surgeries during the 
beginning of the COVID-19 outbreak, based on a com-
parison of guidelines published in 15 countries.
Methods
A network of GPs from various countries, all belong-
ing to the international GP organisation WONCA, col-
laborated in the following three-step protocol to identify 
similarities and differences in GP surgery reorganisation 
between their home countries:
Step 1: Identification of an initial set of key recom-
mendations for the reorganisation of GP surgeries
RT collected key items relating to GP surgery reor-
ganisation from resources published by the WHO [14] 
and the Centers for Disease Control and Prevention 
(CDC) [15], and dedicated resources for healthcare 
workers at facility level. Key items were then attributed 
to a theme and grouped into categories.
SK then reviewed each category and item for accu-
racy and comprehensibility, and added new items based 
on experiences as healthcare professional from care 
facilities, in consensus with RT. This resulted in an ini-
tial set of key recommendations relating to GP surgery 
reorganisation (See Additional file 1).
Step 2: Selection of guidelines and data collection
Voluntary GP-reviewers participated in this study 
between April  25th and May  5th 2020. They received an 
Excel® file with both instructions and the set of key rec-
ommendations gathered in step 1.
The GP-reviewers were first asked to identify the 
national guidelines published on the topic in their coun-
try. Ideally, these guidelines were issued by health author-
ities and/or GP national colleges. If this was not possible, 
the GP-reviewers were allowed to use any other source 
of guidance commonly used by GPs in their country (e.g. 
letters from GP colleges). For each guideline, each GP-
reviewer specified the provider, the date of publication, 
and pandemic level (number of positive cases and deaths 
at the time of publication).
Each GP-reviewer then analysed the guidelines 
against the set of key recommendations identified in 
step 1, determining:
– Whether the key recommendations were found in 
national guidelines
– Whether there were new recommendations men-
tioned in the national guidelines but missing from 
the initial set of key recommendations.
Despite the lack of GP-reviewers from the United States 
of America within our network, we included the USA in 
this study, as the USA is currently the country with the 
largest numbers of cases and deaths. RT and SK collected 
USA data from other guidelines published by the CDC [13, 
16] and the American Academy of Family Physicians [17].
Step 3: Data analysis, comparison and synthesis
RT collected and compared the analyses provided 
by the GP-reviewers. New recommendations were 
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mapped to existing categories, and if this was not possi-
ble, new categories were created. This resulted in a new 
set of categories and recommendations, which was then 
reviewed by each GP-reviewer. Potential changes were 
considered by RT for the final analysis.
Results
Four types of GP surgery reorganisation were identified 
from the analysis of guidelines issued by 15 countries (see 
Additional file 2).
Theme 1: Reorganisation of GP consultations (Table 1)
All countries recommended alternatives to face-to-face 
consultations, such as phone consultations or telemedi-
cine (Table  1). In cases of face-to-face consultations, 
the guidelines recommended scheduling patient 
appointments to ensure a short waiting time, and re-
scheduling appointments if the patient developed 
respiratory symptoms (due to COVID-19 or not). Dedi-
cated time slots for COVID-19 patients should also be 
organised.
All countries recommended postponing non-urgent 
consultations and procedures, and a few authorized the 
renewal of drug prescriptions by pharmacists during the 
pandemic without a mandatory GP consultation. However, 
almost all countries also highlighted the need for GPs to 
remain in contact with patients with chronic diseases.
Almost all countries recommended remote consul-
tations for the diagnosis and monitoring of COVID-
19 patients (including suspected COVID-19 patients). 
The mode of monitoring differed between countries: 
daily for risk group patients in Sweden and Portugal, 
between days 6 and 8 for France, Italy, and Turkey, or 
until patient recovered in Portugal and Turkey. Most 
countries also recommended developing protocols for 
the rapid triage and assessment of COVID-19 patients. 
Eleven countries developed online tools for GPs, such 
as websites, webinars, or decision tools. Portugal imple-
mented a national online platform accessible to GPs, 
for the tracing and monitoring of COVID-19 patients. 
Some countries also developed dedicated phone cen-
tres and online tools for patient information, such as 
chatbots accessible via Whatsapp® in Spain and Turkey.
Theme 2: Reorganisation of GP surgeries (Table 2)
Recommendations for face-to-face triage stations differed 
between countries (Table  2). Germany, Italy, Poland, 
Romania, Spain, Switzerland, and the USA had the most 
detailed recommendations, whereas other countries, 
such as the UK recommended that all triage should be 
performed remotely, resulting in a lack of guidance con-
cerning face-to-face triage. Triage stations should be 
located outside the facility, with a single point of entry 
and physical barriers. All patients should be screened, 
recorded and should wear a face mask or appropri-
ate alternative. Seven countries also recommended that 
patients should be asked to wash their hands, and, in 
Switzerland, it was recommended that patients be asked 
not to touch doors and door handles. It was also recom-
mended that the number of people accompanying the 
patient should be limited and, in Spain, that these indi-
viduals should also wear face masks. Hygiene supplies 
and visuals alerts recapping symptoms and personal 
hygiene measures should be clearly visible. Similarly, vis-
ual signs should clearly indicate the path to be followed 
by the patient with the surgery.
Waiting room recommendations were less detailed in 
New Zealand, Portugal, Sweden, and UK. In New Zea-
land, this was explained by the absence of waiting rooms 
(patients waited outside in their own vehicles). Ideally, GP 
surgeries should have two different waiting rooms: one for 
COVID-19 patients, and one for non-COVID-19 patients. 
If this is not possible, then the waiting room had to be 
partitioned with lines. Unnecessary furniture should be 
removed, and only hygiene supplies and washable chairs 
should be present. Distancing rules, sufficient ventilation 
and regular disinfection should also be respected.
Recommendations regarding the examination room 
were less detailed in France, Portugal, Sweden and USA. 
Ideally, GP surgeries should have a dedicated COVID-
19 examination room with a closed door. Spain recom-
mended having a telephone examination room for the 
remote assessment of patients. Germany recommended 
having special consultation hour for children, to limit 
virus transmission. Staff entering in the examination 
room should be recorded and their numbers limited. 
Surfaces should be disinfected, including all surfaces 
in contact with patients, computers, and telephones. 
Medical equipment should be single-use or sterilized 
between uses and reserved exclusively for COVID-19 
patients.
Theme 3: Reorganisation of medical examinations by GPs 
(Table 3)
All countries recommended that GPs should wear surgi-
cal masks during medical examinations (Table  3). They 
also recommended the wearing of eye protection, gloves 
(except France and Sweden), and gowns (except France, 
Germany and Sweden). Ideally, PPE should be changed 
between patients, but if this is not possible, its disinfec-
tion was recommended in Germany and the USA. Some 
countries also advised the planning of PPE use in case of 
shortages, whereas others, such as the UK, organised a 
hotline for GPs in case of shortage.
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Italy was the only country to recommended avoiding 
performing clinical examinations on COVID-19 patients, 
particularly in the absence of appropriate PPE. France, 
New Zealand, Poland and Romania recommended not 
performing ear nose and/or throat examinations, and 
Norway, Poland and Sweden recommended that the doc-
tor should stay at least 2 metres away from the patient.
Almost all countries recommended hand hygiene after 
patient examination and after touching objects belonging 
to patients. GPs should also refrain from touching their 
eyes, nose or mouth, but some countries also recom-
mended tying up long hair, shaving off beards and remov-
ing jewellery and nail varnish.
France, Germany, Poland, Romania and US recom-
mended patient education on personal hygiene and home 
care. Germany and Spain also recommended education 
about contact management. Romania and Spain also 
advised doctors to try to minimise patient anxiety. Nor-
way was the only country to recommend avoiding cash 
payments for consultations.
Theme 4: Reorganisation of GP surgery staff (Table 4)
Recommendations concerning the staff of GP surgeries 
were limited (Table 4).
Germany, Poland, Turkey, and the USA recommended 
equipping triage staff with facemasks, whereas France, 
Spain and Turkey recommended equipping cleaning staff 
with appropriate PPE. France also recommended not 
using a vacuum cleaner for floor cleaning.
Norway and Switzerland recommended protecting vul-
nerable staff, and Germany and the USA advised check-
ing staff daily. Germany, Norway, Poland, and Turkey 
recommended isolating symptomatic staff at home, but 
Germany authorised staff exposed to COVID-19 but 
no symptoms to work, preconditioned they wore medi-
cal masks, in cases of staff shortage. Turkey was the only 
country recommending a sharing of duties at the GP 
practice and that staff should support each other.
Germany and the USA recommended allocating time 
to staff meetings, to educate staff about COVID-19. Nor-
way advised to holding meetings by video-link and avoid-
ing meetings over lunch.
All countries except Italy and Switzerland recom-
mended working with local organisations to improve 
evaluations of the impact and spread of the outbreak in 
the surrounding area. Only the USA recommended col-
laborating with the local community to assist patients 
isolated at home (e.g. food delivery).
Discussion
This is the first study to provide a multi-country overview 
of recommendations for the reorganisation of GP surger-
ies during the COVID-19 outbreak. Based on guidelines 
published in 15 countries, we reveal the diversity of rec-
ommendations and identify four different types of reor-
ganisation for which recommendations have been issued: 
GP consultations, GP surgeries, clinical examinations 
performed by the GP, and GP surgery staff. The recom-
mendations concerning GP surgery staff were limited in 
all countries.
Strengths and weaknesses
This study has several strengths. Data were identified, 
collected and analysed by medical doctors belonging 
to an international GP network, with knowledge of the 
field of general medicine in practice. Their background 
as GPs made it possible to combine and compare com-
plex guidelines in the form of “practical actions” use-
ful for clinical practice, readily understandable by GPs 
and health policy-makers, of particular utility for coun-
tries in which such guidelines have yet to be developed. 
Moreover, this work provides an overview of recom-
mendations published in a large panel of countries, with 
diverse national health systems, from the North, South, 
and East of Europe, but also from New Zealand and the 
USA, although no low-income or Asian countries were 
included.
This work also has some limitations. First our work 
focuses on comparing guidelines released at the very 
beginning of the pandemic. Some recommendations may 
have evolved quickly, varying per country (e.g., advices 
about the management of vulnerable patients [18], or 
recommendations about the diagnosis of COVID-19 
in GP surgeries based on clinical symptoms [19] or on 
SARS-Cov2 testing [20], depending on the availability 
of diagnostic tests). However, as health care systems are 
being reorganized faster due to COVID-19 outbreak, this 
analysis is an opportunity to present a starting live sys-
tematic review that could then be continuously shared 
and updated within the primary care community. Sec-
ond, comparisons between guidelines in different coun-
tries are risky, particularly during a pandemic period. 
Indeed, similarities or differences may be due the char-
acteristics of the country, such as its population size, the 
prevalence of individuals at risk, pandemic level, or pub-
lic health measures [21, 22]. However, our aim here was 
not to compare the successes and failures of the various 
countries, but to provide a global overview of guidelines 
relating to the organisation of GP surgeries. Indeed, the 
health emergency has forced health policy-makers to 
release guidelines rapidly, not always based on strong 
evidence, but justified by the precautionary principle. 
This has resulted in many concerns, particularly for GPs 
seeking answers outside their own country. Our findings 
should provide answers to some of the questions of GPs, 
although further evaluations are required to assess the 
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level of evidence supporting the recommendations com-
piled here.
Implications for policy-makers: applicability of guidelines 
during the pandemic
The strict application of guidelines is not an easy task in 
routine care. Previous studies have shown that GPs are 
reluctant to follow guidelines, particularly if unclear or 
not supported by evidence [23, 24], or if they cause major 
changes in routine care [23, 25]. A recent Cochrane 
review showed that adherence during the pandemic also 
depended on the complexity of the guidelines and the 
frequency with which they were updated [26]. However, 
given the huge impact of COVID-19, we assume that GPs 
would be receptive to well-written concise guidelines 
helping them to organise their care.
The application of guidelines may also depend on the 
characteristics of the GP surgery. Nothing has yet been 
published on this topic, but we hypothesise that GPs 
working on their own may face greater difficulties per-
forming triage, examinations and regular cleaning, 
whereas GPs in group practices can share these roles. 
Likewise, small surgeries may find it more difficult to 
reorganise their practices than larger surgeries. The 
application of guidelines is also dependent on national 
health policies. For example, GPs have reported being 
unable to follow PPE recommendations properly [27] 
because of national PPE shortages.
Some GPs have also developed ingenious methods of 
facing the pandemic, outside the framework of official 
guidelines. These innovations include, delivering paper 
prescriptions via a window [28] and performing rapid 
assessments in the patient’s car [28]. Some GP-reviewers 
also reported having collected PPE from the population 
and from other healthcare professionals, or having cre-
ated temporary “hot hubs” (or local COVID-19 centres) 
with other local GPs and the local community [28].
Further studies are required to assess the adoption of 
these guidelines by GPs, and their efficacy in the face of 
the pandemic.
Implications for clinicians: use of digital health strategies 
during the pandemic
The rapid spread of COVID-19 and the possibility of GP 
surgeries acting as sources of contagion accelerated the 
adoption of digital health strategies in GP surgeries [29].
The use of telemedicine has greatly increased during 
the pandemic and was recommended by all 15 countries 
included in this study. Guidance concerning video con-
sultations [29, 30], the various providers [31], and the 
performance of remote medical examinations [9], was 
rapidly published in several countries. Some countries 
also took emergency measures, such as authorising the 
integral reimbursement of telemedicine consultations, 
or authorising the use of Skype®, Facetime® and What-
sApp®, despite the need to guarantee security during 
such consultations [32]. Telemedicine has a number of 
advantages during a pandemic: shorter consultation and 
triage times, maintenance of contact with patients with 
chronic diseases and the minimisation of patient expo-
sure to contagion [33]. However, it is too early to deter-
mine whether these practices are likely to continue after 
the pandemic [32, 34, 35], due to limitations, such as the 
risk of social inequalities (e.g. old people, the homeless, 
without access to Internet) [32], the risk of technical fail-
ure, and the lack of evidence that telemedicine is as effec-
tive as face-to-face consultations [36]. Further studies are 
required to assess the impact of telemedicine on patient 
care in the next few months.
Online tools for patients were also rapidly imple-
mented during the outbreak. Educational materials 
were made available on government websites, to inform 
and educate the population. Additional interactive tools 
were also implemented in some countries. For example, 
France developed two decision support tools for self-
assessments of levels of severity and susceptibility; the 
UK developed the NHS 111 online system for symptom 
checking; Spain developed “Hispabot covid-19”, a chat-
bot accessible by WhatsApp, for providing patients with 
automatic answers to their questions. Digital health solu-
tions may be useful for alleviating the pressure on GP 
surgeries due to unnecessary consultations during a pan-
demic, but also for epidemiological surveillance by health 
authorities [37].
Urgent need: involvement of GP surgeries in data 
collection for surveillance and clinical research
During the pandemic, the principal concern has been the 
reorganisation of GP surgeries for clinical care. However, 
it is also important to consider reorganisation for surveil-
lance and clinical research, particularly as the computeri-
sation of GP surgeries in recent decades [38] has greatly 
facilitated the collection of patient data.
The collection of data from GP surgeries would facili-
tate the assessment of treatments for preventing severe 
forms of COVID-19. However, research on these aspects 
is currently concentrated in hospitals: prediction models 
are based on data collected in hospitals [39]; and most 
of the clinical trials are conducted in hospitals [40]. Two 
months after the announcement of the pandemic by the 
WHO, only 23 clinical trials were registered with clini-
calstrials.gov for primary care, and only 11 of these had 
begun to recruit patients (as of May  7th 2020) [40]. GP 
surgeries should be reorganised and included in clinical 
trials assessing the efficacy of drugs for preventing severe 
forms of COVID-19 in primary care.
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Data collection by GP surgeries is also essential for 
epidemiological surveillance [41]. Most cases are man-
aged in primary care, but many countries are monitor-
ing the pandemic through daily numbers of positive 
PCR-tests, deaths, calls to emergency phone centres, 
visits to emergency departments, and COVID-19 beds 
in intensive care units. However, these indicators pro-
vide a delayed and partial picture of the pandemic. A 
consideration of the clinical syndromes reported by GPs 
would facilitate the earlier and more accurate detection 
of peaks in disease incidence [42]. GP surgeries should 
therefore be reorganised to allow a real-time monitoring 
of the COVID-19 outbreak [43] (e.g. indicators included 
in electronic health records [44] or sentinel surveillance 
networks with selected GP practices and hospitals [45]).
Conclusions
We provide here a multi-country overview of guidelines 
for reorganising GP surgeries during the beginning of 
the COVID-19 outbreak from 15 countries. Most of the 
guidelines focused on clinical care, with fewer focusing 
on staff management, and epidemiological surveillance 
and research largely neglected. Our findings should help 
GPs and decision-makers to adapt GP practices in pub-
lic health emergencies, such as the COVID-19 outbreak, 
even if strong evidence is lacking for some recommenda-
tions and further evaluations are required. The impact of 
the reorganisation of GP surgeries on patient care should 
be assessed once the COVID-19 pandemic is over. Addi-
tionally, it would be helpful to propose a library of inter-
national primary care guidelines and tools to support 
countries in continuing guidance optimization, but also 
to provide historical documentation for the primary care 
community.
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